(Q34112985)

31 July 2017

1 reference

title

ZD1839 ('Iressa') as an anticancer agent (English)

1 reference

31 July 2017

J Baselga

1

1 reference

31 July 2017

S D Averbuch

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

60 Suppl 1

1 reference

31 July 2017

page(s)

33-40; discussion 41-2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060001-00004

31 July 2017

exact match

0 references

cites work

The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

1 reference

12 December 2020

Chemotherapy for non-small cell lung cancer: have we reached a new plateau?

1 reference

12 December 2020

Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the eastern cooperative oncology group experience

1 reference

12 December 2020

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor

1 reference

12 December 2020

Regulation of signal transduction and signal diversity by receptor oligomerization

1 reference

12 December 2020

Tyrosine kinases and their interactions with signalling proteins

1 reference

12 December 2020

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

12 December 2020

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

1 reference

12 December 2020

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

1 reference

12 December 2020

Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.

1 reference

12 December 2020

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

12 December 2020

Growth factors and cancer

1 reference

12 December 2020

10.2165/00003495-200060001-00004

Identifiers

DOI

0 references

Dimensions Publication ID

1049769296

0 references

1 reference